110 related articles for article (PubMed ID: 9915108)
1. Efficacy of long-term sulfamethoxazole-trimethoprim therapy in a boy with hyperimmunoglobulin E syndrome.
Tanaka H; Ito R; Onodera N; Waga S
Tohoku J Exp Med; 1998 Sep; 186(1):61-6. PubMed ID: 9915108
[TBL] [Abstract][Full Text] [Related]
2. Successful trimethoprim-sulfamethoxazole therapy in a patient with hyperimmunoglobulin E syndrome.
Hattori K; Hasui M; Masuda K; Masuda M; Ogino H; Kobayashi Y
Acta Paediatr; 1993 Mar; 82(3):324-6. PubMed ID: 8495097
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
Bell TL; Foster JN; Townsend ML
Pharmacotherapy; 2010 May; 30(5):539. PubMed ID: 20412003
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic failure of trimethoprim/sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia.
al-Tawfiq JA; Sorensen SJ; Cushing HE
Ann Pharmacother; 1999 Apr; 33(4):413-5. PubMed ID: 10332530
[TBL] [Abstract][Full Text] [Related]
6. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
7. Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim (SMX-TMP).
Kobayashi Y; Amano D; Ueda K; Kagosaki Y; Usui T
Eur J Pediatr; 1978 Apr; 127(4):247-54. PubMed ID: 668710
[TBL] [Abstract][Full Text] [Related]
8. Reduction in mortality from gram-negative sepsis in neutropenic patients receiving trimethoprim/sulfamethoxazole therapy.
Riben PD; Louie TJ; Lank BA; Kornachuk E; Gurwith MJ; Harding GK; Ronald AR
Cancer; 1983 May; 51(9):1587-92. PubMed ID: 6339029
[TBL] [Abstract][Full Text] [Related]
9. Intravenous trimethoprim-sulfamethoxazole alone or combined with tobramycin for infections in cancer patients.
Grose WE; Bodey GP
Am J Med Sci; 1980; 279(1):4-13. PubMed ID: 7369247
[TBL] [Abstract][Full Text] [Related]
10. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA
Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
[TBL] [Abstract][Full Text] [Related]
11. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
Grim SA; Rapp RP; Martin CA; Evans ME
Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
[TBL] [Abstract][Full Text] [Related]
12. Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections.
Ellison RT; Judson FN; Peterson LC; Cohn DL; Ehret JM
West J Med; 1984 May; 140(5):735-40. PubMed ID: 6610253
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of acute bone and joint infections.
Bajpai J; Chaturvedi SN; Khanuja SP
Int Surg; 1977 Mar; 62(3):172-4. PubMed ID: 323174
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes in patients hospitalized with cellulitis treated with oral clindamycin and trimethoprim/sulfamethoxazole: The role of weight-based dosing.
Cox KK; Alexander B; Livorsi DJ; Heintz BH
J Infect; 2017 Dec; 75(6):486-492. PubMed ID: 28919346
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic treatment of acute shigellosis: failure of cefamandole compared with trimethoprim/ sulfamethoxazole and ampicillin.
Orenstein WA; Ross L; Overturf GD; Wilkins J; Redfield DR; Underman A
Am J Med Sci; 1981; 282(1):27-33. PubMed ID: 7270569
[TBL] [Abstract][Full Text] [Related]
16. Influence of ionizing radiation on the antimicrobial activity of the antibiotics sulfamethoxazole and trimethoprim.
Sági G; Szabacsi K; Szabó L; Homlok R; Kovács K; Mohácsi-Farkas C; Pillai SD; Takács E; Wojnárovits L
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2018 Jul; 53(8):687-693. PubMed ID: 29485359
[TBL] [Abstract][Full Text] [Related]
17. A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
Harding GK; Ronald AR; Boutros P; Lank B
Can Med Assoc J; 1975 Jun; 112(13 Spec No):9-12. PubMed ID: 1093658
[TBL] [Abstract][Full Text] [Related]
18. Comparison of trimethoprim-sulfamethoxazole and ampicillin theraphy for shigellosis in ambulatory.
Nelson JD; Kusmiesz H; Jackson LH
J Pediatr; 1976 Sep; 89(3):491-3. PubMed ID: 1048183
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial prophylaxis in chronic granulomatous disease. A case report.
Mendelsohn HB; Berant M; Merzbach D
Isr J Med Sci; 1983 Nov; 19(11):1004-5. PubMed ID: 6607239
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
Brown PD; Freeman A; Foxman B
Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
